Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40400-15-5 | MDL No. : | MFCD00040888 |
Formula : | C8H6IN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FPSGTRJUQLYLHE-UHFFFAOYSA-N |
M.W : | 243.04 | Pubchem ID : | 4402282 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 48.68 |
TPSA : | 23.79 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.99 cm/s |
Log Po/w (iLOGP) : | 1.82 |
Log Po/w (XLOGP3) : | 2.52 |
Log Po/w (WLOGP) : | 2.36 |
Log Po/w (MLOGP) : | 2.67 |
Log Po/w (SILICOS-IT) : | 3.1 |
Consensus Log Po/w : | 2.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.31 |
Solubility : | 0.118 mg/ml ; 0.000487 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.67 |
Solubility : | 0.525 mg/ml ; 0.00216 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.84 |
Solubility : | 0.0348 mg/ml ; 0.000143 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | Stage #1: With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 0.0833333 h; Inert atmosphere Stage #2: at -78℃; for 0.0833333 h; |
Under N2 protection,The re-distilled dichloromethane (5 mL) was added to a 25 ml reaction tube.Then 161 mg (0.5 mmol) of iodobenzene diacetate was added.Then 180 μl of trimethylsilyl triflate (TMSOTf, 1.0 mmol) was added.The reaction solution was stirred at room temperature for 5 min.Finally, 198 mg (0.6 mmol) of α-tributyltin acetonitrile was added at -78 °C.Stir for 5min,Track the progress of the reaction by thin layer chromatography.After the reaction was completed, a saturated sodium hydrogencarbonate solution (3 ml) was added to quench the reaction.Slowly warm to room temperature,Then extracted with dichloromethane (3 mL×3).The organic phase is dried over anhydrous sodium sulfate.Concentrated in vacuo,Separated by column chromatography (Rf = 0.19, developing solvent: petroleum ether / ethyl acetate = 40/1, v/v),Product obtainedThe α-aryl nitrile compound is a white solid.The yield was 86percent. |
[ 1227311-09-2 ]
4-Iodo-3,5-dimethylbenzonitrile
Similarity: 0.83
[ 866996-02-3 ]
4-Ethyl-1-iodo-2-methylbenzene
Similarity: 0.81
[ 1227311-09-2 ]
4-Iodo-3,5-dimethylbenzonitrile
Similarity: 0.83